首页 | 本学科首页   官方微博 | 高级检索  
     


Randomized Multicenter and Stratified Phase II Study of Gemcitabine Alone Versus Gemcitabine and Docetaxel in Patients with Metastatic or Relapsed Leiomyosarcomas: A Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study)
Authors:Patricia Pautier  Anne Floquet  Nicolas Penel  Sophie Piperno‐Neumann  Nicolas Isambert  Annie Rey  Emmanuelle Bompas  Angela Cioffi  Corinne Delcambre  Didier Cupissol  Françoise Collin  Jean‐Yves Blay  Marta Jimenez  Florence Duffaud
Affiliation:1. aDepartment of Medical Oncology and;2. cDepartment of Medical Oncology, Institut Bergonié, Bordeaux, France;3. dDepartment of Medical Oncology, Centre Oscar Lambret, Lille, France;4. eInstitut Curie, Paris, France;5. gDepartment of Medical Oncology, Centre Georges‐Frano?is Leclerc, Dijon, France;6. bDepartment of Biostatistics, Institut Gustave‐Roussy, Villejuif, France;7. hCentre René Gauducheau, Nantes, France;8. iCentre Frano?is Baclesse, Caen, France;9. jCentre Val d'Aurelle, Montpellier, France;10. fDepartment of Pathology and;11. kH?pital Edouard Herriot and Centre Léon Bérard, Lyon, France;12. lFédération Nationale des Centres de Lutte Contre le Cancer, Paris, France;13. mDepartment of Medical Oncology, La Timone University Hospital, Marseille, France
Abstract:
Keywords:Leiomyosarcoma  Chemotherapy  Docetaxel  Gemcitabine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号